confirmed that HERG1 induces to poor prognosis in esophageal squamous cell carcinoma (ESCC) patients by promoting cell proliferation, migration, and invasion, while these effects can be reversed by altering the expression of TXNDC5 and its downstream PI3K/AKT pathway. This evidence concerns the gene KCNH2 and esophageal squamous cell carcinoma.